Respiratory syncytial virus (RSV) is a leading cause of illness and hospitalization among very young children. This is an experimental vaccine to protect against RSV elicited high levels of RSV-specific antibodies when tested in animals, according to a report in the journal emScience/em. Early-stage human clinical trials of the candidate vaccine are planned. Scientists from the Vaccine Research Center (VRC), National Institute of Allergy and Infectious ...You have just read an article categorized health
titled Candidate Vaccine Against Respiratory Syncytial Virus Developed.
Written by:
editor - Monday, November 4, 2013
There are currently no comments for "Candidate Vaccine Against Respiratory Syncytial Virus Developed"
Post a Comment